Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Seminars in Oncology|February 1, 1997
Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II studyG Fountzilas, A Athanassiadis, E Samantas, et al.
Medical and Pediatric Oncology|June 1, 1997
Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group studyG Fountzilas, P Kosmidis, V Avramidis, et al.
Anticancer Research|May 6, 1998
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancerA Kalogera-Fountzila, P Kosmidis, C Bacoyiannis, et al.
Oncology|November 6, 2002
Docetaxel in combination with dacarbazine in patients with advanced melanomaD Bafaloukos, G Aravantinos, G Fountzilas, et al.
Medical and Pediatric Oncology|January 1, 1994
Evaluation of six tumor markers in patients with carcinoma of unknown primaryN Pavlidis, J Kalef-Ezra, E Briassoulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group studyD V Skarlos, E Samantas, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)P Kosmidis, N Mylonakis, D Skarlos, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic studyP Kiriakogiani-Psaropoulou, V Malamou-Mitsi, U Martinopoulou, et al.
Chemotherapy|May 1, 1996
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancerN Tsavaris, K Tentas, P Kosmidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology GroupA Bamias, Ch Deliveliotis, G Fountzilas, et al.
Pageof 15